INBODY 1

Skin lighteners are a growing class of skin care and increasingly cosmetic companies are introducing a variety of skin lightening products. Major growth in skin whitening demand is occurring in Asia many consumers in Europe and the USA looking for product to achieve evenness in complexion, lighter skin tones and to reduce discolorations caused by age spots, freckles and hyper pigmentation.

Hydroquinone remains the most popular of skin whitening actives and is used in most creams at 4% concentration however some products are available at a dangerously high 10%. Hydroquinone works by inhibiting the conversion of the enzyme tyrosine to the skin pigment melanin – the higher the concentration of melanin the darker the skin.

The efficacy of Hydroquinone is directly related to the concentration of the preparation however as with most skin care more is not necessarily better. With the use of Hydroquinone at higher levels the greater the chance of irritation, allergic reactions, nail discoloration, skin de pigmentation in isolated areas and the creation of dark spots (hyper pigmentation).

The use of Hydroquinone in skin care is banned in many countries including Japan, the European Union, South Africa, New Zealand and Australia. The US FDA has also signaled its intent to ban Hydroquinone citing it as being a cause of leukemia and kidney damage (in animal studies). Hydroquinone also has been linked with the medical condition known as ochronosis in which the skin becomes dark and thick.

The INBODY Skin Whitening formula contains a natural alternatives to Hydroquinone, this new generation skin lightener uses natural plant extracts producing results equivalent to Hydroquinone with out the associated risks.

Key to the performance of the INBODY Skin Whitening formula is a unique ingredient combining a Pea Extract (Pisum Sativum) with sugar esters, glycerine and water.

This novel ingredient in trials has demonstrated proven performance with optimal whitening efficacy and is well tolerated by the skin and allows daily use.

In clinical trials (on Asian skin) the Pea Extract offered a high capacity to decrease melanogenesis – the process which is responsible for the creation of melanin, which in turn is responsible for the coloration of the human skin. This product property is linked to a decrease of tyrosinase activity in melanocytes and also to an inhibition of melanosome maturation. The dual biological pathway results in a whitening efficacy matching the market benchmark (Hydroquinone)and a visible reduction of skin pigmentation.

Ingredients